Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomics of Anti-Platelet Interventions (PAPI)
NCT00799396Phase 4Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jul 2006
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel, aspirin in coronary heart disease (CHD), sponsored by University of Maryland, Baltimore. Started Jul 2006; status: completed.
02
Drugs
clopidogrelaspirin
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00799396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799396.